- Home
- CDXS vs WLAC Comparison
CDXS vs WLAC Comparison
Compare CDXS & WLAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- WLAC
- Stock Information
- Founded
- CDXS 2002
- WLAC 2024
- Country
- CDXS United States
- WLAC United States
- Employees
- CDXS N/A
- WLAC N/A
- Industry
- CDXS Major Chemicals
- WLAC
- Sector
- CDXS Industrials
- WLAC
- Exchange
- CDXS Nasdaq
- WLAC Nasdaq
- Market Cap
- CDXS 201.3M
- WLAC 172.6M
- IPO Year
- CDXS 2010
- WLAC 2024
- Fundamental
- Price
- CDXS $2.27
- WLAC $10.20
- Analyst Decision
- CDXS Buy
- WLAC
- Analyst Count
- CDXS 2
- WLAC 0
- Target Price
- CDXS $11.00
- WLAC N/A
- AVG Volume (30 Days)
- CDXS 1.0M
- WLAC 3.6K
- Earning Date
- CDXS 08-07-2025
- WLAC 01-01-0001
- Dividend Yield
- CDXS N/A
- WLAC N/A
- EPS Growth
- CDXS N/A
- WLAC N/A
- EPS
- CDXS N/A
- WLAC N/A
- Revenue
- CDXS $49,815,000.00
- WLAC N/A
- Revenue This Year
- CDXS $12.77
- WLAC N/A
- Revenue Next Year
- CDXS $22.12
- WLAC N/A
- P/E Ratio
- CDXS N/A
- WLAC $753.14
- Revenue Growth
- CDXS N/A
- WLAC N/A
- 52 Week Low
- CDXS $1.90
- WLAC $9.80
- 52 Week High
- CDXS $6.08
- WLAC $10.60
- Technical
- Relative Strength Index (RSI)
- CDXS 48.16
- WLAC N/A
- Support Level
- CDXS $2.20
- WLAC N/A
- Resistance Level
- CDXS $2.51
- WLAC N/A
- Average True Range (ATR)
- CDXS 0.14
- WLAC 0.00
- MACD
- CDXS -0.00
- WLAC 0.00
- Stochastic Oscillator
- CDXS 42.65
- WLAC 0.00
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About WLAC Willow Lane Acquisition Corp. Class A Ordinary Shares
Willow Lane Acquisition Corp is a blank check company.